Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Perspectives] Prostate cancer

For much of human history men have not, typically, lived long enough to die from prostate cancer. Descriptions of terminal dribbling, urinary retention, and the signs of bony metastases can be found in case records from many times and places, but patients and practitioners seem to have regarded them as the price to be paid for surviving into middle age and beyond. Surgeons occasionally tried to ease their patients’ suffering with catheterisation—one unnamed British patient in the early 19th century was catheterised almost 7000 times—or dilating the prostate with a probe.